Cargando…
PAX5 alterations in B-cell acute lymphoblastic leukemia
PAX5, a master regulator of B cell development and maintenance, is one of the most common targets of genetic alterations in B-cell acute lymphoblastic leukemia (B-ALL). PAX5 alterations consist of copy number variations (whole gene, partial, or intragenic), translocations, and point mutations, with...
Autores principales: | Jia, Zhilian, Gu, Zhaohui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640836/ https://www.ncbi.nlm.nih.gov/pubmed/36387144 http://dx.doi.org/10.3389/fonc.2022.1023606 |
Ejemplares similares
-
MD-ALL: an Integrative Platform for Molecular Diagnosis of B-cell Acute Lymphoblastic Leukemia
por: Gu, Zhaohui, et al.
Publicado: (2023) -
Distinct clinical characteristics of DUX4- and PAX5-altered childhood B-lymphoblastic leukemia
por: Li, Zhenhua, et al.
Publicado: (2021) -
Leukemia-Initiating Cells in T-Cell Acute Lymphoblastic Leukemia
por: Tan, Shi Hao, et al.
Publicado: (2017) -
PAX5 fusion genes in acute lymphoblastic leukemia: A literature review
por: Fouad, Fatma Mohamed, et al.
Publicado: (2023) -
Pax5 loss imposes a reversible differentiation block in B-progenitor acute lymphoblastic leukemia
por: Liu, Grace J., et al.
Publicado: (2014)